Atjaunināt sīkdatņu piekrišanu

E-grāmata: Congenital Bleeding Disorders: Diagnosis and Management

  • Formāts: EPUB+DRM
  • Izdošanas datums: 27-Dec-2023
  • Izdevniecība: Springer International Publishing AG
  • Valoda: eng
  • ISBN-13: 9783031431562
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 213,54 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Izdošanas datums: 27-Dec-2023
  • Izdevniecība: Springer International Publishing AG
  • Valoda: eng
  • ISBN-13: 9783031431562
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

This significantly updated new edition describes in detail the clinical presentations, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare bleeding disorders such as congenital factor V, factor X, factor XI, and factor XIII deficiency and inherited platelet function disorders. The exceptional attention to rarer conditions is of particular importance given the considerable risk of overlooking them during diagnosis, with potential consequences for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees.

 An Overview of Hemostasis.- Congenital Bleeding Disorders: Diagnosis
and Management.- von Willebrand disease: an update on diagnosis and
treatment.- Hemophilia A, Diagnosis and Management.- Hemophilia B, Diagnosis
and Management.- Congenital fibrinogen disorders, diagnosis, and management.-
Congenital Prothrombin Deficiency: Diagnosis and Management.- Congenital
Factor V Deficiency.- Combined Factor V and Factor VIII Deficiency, Diagnosis
and Management.- Congenital Factor VII Deficiency, Diagnosis and Management.-
Vitamin K-dependent Coagulation Factors Deficiency, Diagnosis and
Management.- Congenital Factor X deficiency, Diagnosis and Management.-
Congenital Factor XI Deficiency.- Congenital Factor XIII Deficiency,
Diagnosis and Management.- Glanzmann Thrombasthenia.- Bernard-Soulier
Syndrome, Diagnosis and Management.- Gray Platelet Syndrome (GPS).




 
Akbar Dorgalaleh is a hematologist and scientific researcher in the field of thrombosis and hemostasis.  He has (co-)authored over 120 papers, and is a member of the editorial boards of several international journals.





Dr. Dorgalaleh is also a current or past member of several International scientific societies or working parties, including International Society on Thrombosis and Hemostasis (ISTH) Scientific Standardization Committees (SSCs) on Subcommittee on Factor XIII and Fibrinogen and International Council for Standardization in Haematology (ICSH).